Holen Sie sich die Stockscreener-App
3.78
3.08%
-0.12
Vorhandelsmarkt:
3.65
-0.13
-3.44%
Heartsciences Inc Aktie (HSCS) Neueste Nachrichten
FDA Grants Breakthrough Device Designation for HeartSciences' AI-ECG Algorithm - Diagnostic and Interventional Cardiology
HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis - Investing News Network
HeartSciences recesives FDA BDD for Aortic Stenosis ECG algorithm - MSN
HeartSciences (HSCS) Gains FDA Breakthrough Status for AI ECG Al - GuruFocus
Heart Test Laboratories Receives FDA Breakthrough Designation - TipRanks
HeartSciences (HSCS) Gains FDA Breakthrough Status for AI ECG Algorithm | HSCS Stock News - GuruFocus
Revolutionary AI Algorithm Detects Silent Killer Heart Disease 2 Years Earlier, FDA Fast-Tracks Approval - Stock Titan
Heart Test Laboratories Files Certificate for Preferred Stock - TipRanks
HeartSciences announces grant by USPTO for ECG assessment of heart function - TipRanks
HeartSciences Inc. Announces the Grant by the United States Patent and Trademark Office of A foundational Patent Covering the Establishing the Estimation of Echocardiography parameters Indicative of Heart Function Using an ECG - marketscreener.com
Heart Test Laboratories Secures Foundational Patent for AI-ECG - TipRanks
HeartSciences (HSCS) Strengthens IP Portfolio with New Patent Grant | HSCS Stock News - GuruFocus
HeartSciences Inc. Secures Foundational Patent for AI-Driven ECG Technology Enhancing Heart Function Detection - Nasdaq
Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences' Patent Portfolio and IP Value - The Manila Times
Revolutionary AI Patent: HeartSciences Transforms ECG Technology for Earlier Heart Disease Detection - Stock Titan
HeartSciences signs first MyoVista Insights platform customer - Yahoo Finance
HeartSciences Inc. Signs First MyVista Insights Platform Customer - marketscreener.com
HeartSciences Signs First MyoVista Insights(TM) Platform Customer - marketscreener.com
HeartSciences (HSCS) Secures First Client for MyoVista Insights in the UK | HSCS Stock News - GuruFocus
HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone - GlobeNewswire
HeartSciences amends corporate articles By Investing.com - Investing.com Canada
HeartSciences amends corporate articles - Investing.com
Heart Test Laboratories Announces $15M Securities Offering - TipRanks
Heart Test Labs Granted Nasdaq Compliance Extension - MSN
HeartSciences' CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025 - The Manila Times
HeartSciences Unveils Game-Changing AI-Powered ECG Platform: CEO Presents Investment Opportunity Tomorrow - Stock Titan
HeartSciences receives Nasdaq compliance extension - Investing.com
HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025Featuring CEO Andrew Simpson - The Manila Times
HeartSciences (HSCS) Enhances Team with Key Scientific Advisory Appointments | HSCS Stock News - GuruFocus
HeartSciences Inc. Expands Scientific Advisory Board with Three New Appointments to Enhance AI-Driven Cardiac Care - Nasdaq
HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board - The Manila Times
HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results - ADVFN
HeartSciences launches MyoVista Insights platform - TipRanks
HeartSciences (HSCS) Unveils MyoVista Insights Platform | HSCS S - GuruFocus
HeartSciences (HSCS) Unveils MyoVista Insights Platform | HSCS Stock News - GuruFocus
HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program - The Manila Times
Lifestyle Icon Martha Stewart Confirmed As Vivid Sydney 2025's Global Storyteller - Barchart.com
This AI Company Is Solving A 100+ Year-Old Health Problem - Barchart.com
Northstar Secures 15-Year Lease Extension For Delta, BC Facility - Barchart.com
/R E P E A T -- LASSONDE INDUSTRIES INC. WILL HOLD A CONFERENCE CALL TO DISCUSS ITS Q4 AND FISCAL 2024 RESULTS/ - Barchart.com
HeartSciences faces Nasdaq delisting over equity shortfall By Investing.com - Investing.com Canada
HeartSciences faces Nasdaq delisting over equity shortfall - Investing.com
HeartSciences Reports Third Quarter Fiscal 2025 Financial Results and Business Update on AI-Powered ECG Innovations - Nasdaq
0.54%
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):